Basic population information
The mean age of the A+P group was 52 years (42.5, 59.0), which was
higher than that of the azvudine and paxlovid groups (P=0.025). There
were no significant differences in the sex composition among the three
groups. In terms of comorbidities, there was no significant difference
between the three groups in terms of comorbidity with hypertension and
coronary artery disease; however, the paxlovid group had a higher
proportion of comorbid diabetes than the other two groups (P=0.032).
There were differences in the clinical typing of the novel coronavirus
among the three groups, with the highest proportion of severe and
critical cases in the A+P group (35.5 %). The basic patient profiles
are shown in Table 1.